Pregabalin and Gabapentin Are Safe to Use in Patients with a History of WPW
Both pregabalin and gabapentin are safe to use in patients with a history of Wolff-Parkinson-White (WPW) syndrome, as neither drug affects AV nodal conduction or accessory pathway function—the critical concern in WPW management.
Why These Medications Are Safe
The primary cardiac risk in WPW relates to drugs that block AV nodal conduction, which can paradoxically accelerate conduction through the accessory pathway during atrial fibrillation, potentially leading to ventricular fibrillation and sudden death. The contraindicated medications are clearly defined in guidelines 1, 2, 3:
Class III (Contraindicated) drugs in WPW with pre-excited AF:
- AV nodal blockers: Digoxin, diltiazem, verapamil, beta-blockers
- Adenosine (in wide-complex tachycardias)
- Amiodarone (specifically contraindicated) 2
Mechanism of Safety
Gabapentin and pregabalin work through calcium channel modulation at the α2δ subunit of voltage-gated calcium channels in the central nervous system—a completely different mechanism from cardiac calcium channel blockers (like diltiazem/verapamil) that affect AV nodal conduction 4, 5. These gabapentinoids:
- Do not slow AV nodal conduction
- Do not affect accessory pathway conduction
- Do not appear in any guideline contraindication lists for WPW 1, 2, 1, 3, 1
Important Clinical Caveats
While cardiac conduction is not a concern, gabapentinoids do have relevant side effects to monitor:
Cardiovascular considerations:
- Peripheral edema is dose-dependent and common 4
- Rare reports of heart failure exacerbation exist, primarily in elderly patients with pre-existing cardiac disease 6
- Weight gain can occur
Practical approach:
- Start at lower doses and titrate gradually
- Monitor for peripheral edema, especially if the patient has any underlying cardiac dysfunction
- If heart failure develops (rare), discontinue the medication 6
The Real WPW Concern
The critical issue in WPW is avoiding drugs during active arrhythmias, particularly pre-excited atrial fibrillation. The guidelines are explicit about what to avoid 1, 2, 3:
- Never use: Digoxin, diltiazem, verapamil, beta-blockers, or amiodarone in pre-excited AF
- Use instead: Procainamide, ibutilide, or immediate cardioversion if hemodynamically unstable
For chronic management, patients with symptomatic WPW should undergo catheter ablation as definitive therapy 1, 2.
Bottom Line
Gabapentin and pregabalin pose no specific cardiac conduction risk in WPW patients. They are not mentioned in any WPW contraindication guidelines because they don't affect the accessory pathway or AV node. Use them as you would in any other patient, with standard monitoring for their known side effects (edema, dizziness, somnolence). The only cardiac vigilance needed is the same as for any patient: watch for peripheral edema and avoid use in decompensated heart failure.